Liposome technology for industrial purposes - PubMed (original) (raw)

Liposome technology for industrial purposes

Andreas Wagner et al. J Drug Deliv. 2011.

Abstract

Liposomes, spherical vesicles consisting of one or more phospholipid bilayers, were first described in the mid 60s by Bangham and coworkers. Since then, liposomes have made their way to the market. Today, numerous lab scale but only a few large-scale techniques are available. However, a lot of these methods have serious limitations in terms of entrapment of sensitive molecules due to their exposure to mechanical and/or chemical stress. This paper summarizes exclusively scalable techniques and focuses on strengths, respectively, limitations in respect to industrial applicability. An additional point of view was taken to regulatory requirements concerning liposomal drug formulations based on FDA and EMEA documents.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Bangham AD. Lipid bilayers and biomembranes. Annual Review of Biochemistry. 1972;41:753–776. - PubMed
    1. Sessa G, Weissmann G. Phospholipid spherules (liposomes) as a model for biological membranes. Journal of Lipid Research. 1968;9(3):310–318. - PubMed
    1. Gregoriadis G, Leathwood PD, Ryman BE. Enzyme entrapment in liposomes. FEBS Letters. 1971;14(2):95–99. - PubMed
    1. Rahman YE, Rosenthal MW, Cerny EA, Moretti ES. Preparation and prolonged tissue retention of liposome encapsulated chelating agents. Journal of Laboratory and Clinical Medicine. 1974;83(4):640–647. - PubMed
    1. Lasic DD. Kinetic and thermodynamic effects on the structure and formation of phosphatidylcholine vesicles. Hepatology. 1991;13(5):1010–1012. - PubMed

LinkOut - more resources